Towards host-directed therapies for tuberculosis
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Nature reviews / Drug discovery - 14(2015), 8, Seite 511-512 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zumla, Alimuddin [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1038/nrd4696 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC196120956X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC196120956X | ||
| 003 | DE-627 | ||
| 005 | 20230517122745.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nrd4696 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC196120956X | ||
| 035 | |a (DE-599)GBVOLC196120956X | ||
| 035 | |a (PRQ)c1151-f7f65185db697e5b9c56bcc57afc6ef8874550b7a23fde39a464e50f8e04fed90 | ||
| 035 | |a (KEY)0473973620150000014000800511towardshostdirectedtherapiesfortuberculosis | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Zumla, Alimuddin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Towards host-directed therapies for tuberculosis |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies. | ||
| 650 | 4 | |a Antitubercular Agents - therapeutic use | |
| 650 | 4 | |a Antitubercular Agents - pharmacology | |
| 650 | 4 | |a Antitubercular Agents - administration & dosage | |
| 650 | 4 | |a Mycobacterium tuberculosis - drug effects | |
| 650 | 4 | |a Tuberculosis - drug therapy | |
| 700 | 1 | |a Maeurer, Markus |4 oth | |
| 700 | 1 | |a Chakaya, Jeremiah |4 oth | |
| 700 | 1 | |a Hoelscher, Michael |4 oth | |
| 700 | 1 | |a Ntoumi, Francine |4 oth | |
| 700 | 1 | |a Rustomjee, Roxana |4 oth | |
| 700 | 1 | |a Vilaplana, Cristina |4 oth | |
| 700 | 1 | |a Yeboah-Manu, Dorothy |4 oth | |
| 700 | 1 | |a Rasolof, Voahangy |4 oth | |
| 700 | 1 | |a Munderi, Paula |4 oth | |
| 700 | 1 | |a Singh, Nalini |4 oth | |
| 700 | 1 | |a Aklillu, Eleni |4 oth | |
| 700 | 1 | |a Padayatchi, Nesri |4 oth | |
| 700 | 1 | |a Macete, Eusebio |4 oth | |
| 700 | 1 | |a Kapata, Nathan |4 oth | |
| 700 | 1 | |a Mulenga, Modest |4 oth | |
| 700 | 1 | |a Kibiki, Gibson |4 oth | |
| 700 | 1 | |a Mfinanga, Sayoki |4 oth | |
| 700 | 1 | |a Nyirenda, Thomas |4 oth | |
| 700 | 1 | |a Maboko, Leonard |4 oth | |
| 700 | 1 | |a Garcia-Basteiro, Alberto |4 oth | |
| 700 | 1 | |a Rakotosamimanana, Niaina |4 oth | |
| 700 | 1 | |a Bates, Matthew |4 oth | |
| 700 | 1 | |a Mwaba, Peter |4 oth | |
| 700 | 1 | |a Reither, Klaus |4 oth | |
| 700 | 1 | |a Gagneux, Sebastien |4 oth | |
| 700 | 1 | |a Edwards, Sarah |4 oth | |
| 700 | 1 | |a Mfinanga, Elirehema |4 oth | |
| 700 | 1 | |a Abdulla, Salim |4 oth | |
| 700 | 1 | |a Cardona, Pere-Joan |4 oth | |
| 700 | 1 | |a Russell, James B W |4 oth | |
| 700 | 1 | |a Gant, Vanya |4 oth | |
| 700 | 1 | |a Noursadeghi, Mahdad |4 oth | |
| 700 | 1 | |a Elkington, Paul |4 oth | |
| 700 | 1 | |a Bonnet, Maryline |4 oth | |
| 700 | 1 | |a Menendez, Clara |4 oth | |
| 700 | 1 | |a Dieye, Tandakha N |4 oth | |
| 700 | 1 | |a Diarra, Bassirou |4 oth | |
| 700 | 1 | |a Maiga, Almoustapha |4 oth | |
| 700 | 1 | |a Aseffa, Abraham |4 oth | |
| 700 | 1 | |a Parida, Shreemanta |4 oth | |
| 700 | 1 | |a Wejse, Christian |4 oth | |
| 700 | 1 | |a Petersen, Eskild |4 oth | |
| 700 | 1 | |a Kaleebu, Pontiano |4 oth | |
| 700 | 1 | |a Oliver, Matt |4 oth | |
| 700 | 1 | |a Craig, Gill |4 oth | |
| 700 | 1 | |a Corrah, Tumena |4 oth | |
| 700 | 1 | |a Tientcheu, Leopold |4 oth | |
| 700 | 1 | |a Antonio, Martin |4 oth | |
| 700 | 1 | |a Rao, Martin |4 oth | |
| 700 | 1 | |a McHugh, Timothy D |4 oth | |
| 700 | 1 | |a Sheikh, Aziz |4 oth | |
| 700 | 1 | |a Ippolito, Giuseppe |4 oth | |
| 700 | 1 | |a Ramjee, Gita |4 oth | |
| 700 | 1 | |a Kaufmann, Stefan H E |4 oth | |
| 700 | 1 | |a Churchyard, Gavin |4 oth | |
| 700 | 1 | |a Steyn, Andrie |4 oth | |
| 700 | 1 | |a Grobusch, Martin |4 oth | |
| 700 | 1 | |a Sanne, Ian |4 oth | |
| 700 | 1 | |a Martinson, Neil |4 oth | |
| 700 | 1 | |a Madansein, Rajhmun |4 oth | |
| 700 | 1 | |a Wilkinson, Robert J |4 oth | |
| 700 | 1 | |a Mayosi, Bongani |4 oth | |
| 700 | 1 | |a Schito, Marco |4 oth | |
| 700 | 1 | |a Wallis, Robert S |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews / Drug discovery |d London : Nature Publ. Group, 2001 |g 14(2015), 8, Seite 511-512 |w (DE-627)337806365 |w (DE-600)2062954-0 |w (DE-576)263021246 |x 1474-1776 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2015 |g number:8 |g pages:511-512 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1038/nrd4696 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26184493 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 14 |j 2015 |e 8 |h 511-512 | ||